Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

New agent for CMV infection from Glaxo Wellcome

Oct. 4, 1996

Pharmacia & Upjohn details the activity of new HIV protease inhibitor

Oct. 4, 1996

CMV protease structure reported by three different pharmaceutical companies

Sep. 27, 1996

Immunization with HIV-1 Tat protein as a strategy for AIDS vaccination

Sep. 27, 1996

New launch for dronabinol in AIDS and cancer patients

Sep. 27, 1996

Procept to develop vaginal gel for the prevention of HIV in women

Sep. 27, 1996

Sequus signs international marketing agreement for Caelyx/Doxil

Sep. 27, 1996

Remune phase II trial interim results

Sep. 27, 1996

Anti-HIV agents reported by Japanese researchers

Sep. 27, 1996

Clinical results with VIMRxyn in AIDS

Sep. 27, 1996

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...